# Jubilant Draximage Radiopharmacies Inc, Kansas City, MO – FDA Inspections

Source: https://www.keypedia.com/companies/jubilant-draximage-radiopharmacies-inc/0d63a009-e29b-427f-8704-22af088239fb

> Inspection records and compliance data for Jubilant Draximage Radiopharmacies Inc in Kansas City, Missouri. 2 FDA inspections on record (1 OAI), 1 Form 483, last inspected July 03, 2017.

---

## Details

- Name: Jubilant Draximage Radiopharmacies Inc
- FEI Number: 3008364285
- Facility Type: Producer of Sterile Drugs
- Address Line 1: 712 Westport Rd
- City: Kansas City
- State: Missouri
- Zip Code: 64111
- Country Name: United States
- Address: 712 Westport Rd, Kansas City, Missouri 64111, United States
- Country: United States

## Related Documents

- [UNTITLED_LETTER - Jubilant Draximage Radiopharmacies Inc - 2017-07-03](https://www.keypedia.com/records/untitled_letter/jubilant-draximage-radiopharmacies-inc/a3a86bec-8fd3-43fa-b526-4f2d81bbf3ec) — source: FDA, date: July 3, 2017
- [FDA Inspection 1016625 - Jubilant Draximage Radiopharmacies Inc - 2017-07-03](https://www.keypedia.com/records/fda_inspections/jubilant-draximage-radiopharmacies-inc/ab2e8069-c34f-4a45-bf9b-8973e268c6a0) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 3, 2017
- [483 - Jubilant Draximage Radiopharmacies Inc - 2015-01-09](https://www.keypedia.com/records/483/jubilant-draximage-radiopharmacies-inc/ab27041f-99c5-4a22-ac3b-791da5554c45) — source: FDA, date: January 9, 2015
- [FDA Inspection 909274 - Jubilant Draximage Radiopharmacies Inc - 2015-01-09](https://www.keypedia.com/records/fda_inspections/jubilant-draximage-radiopharmacies-inc/758771d0-d31a-4ff4-8562-5d79ce47e3cd) — classification: Official Action Indicated (OAI), source: FDA, date: January 9, 2015
- [STATE_REFERRAL_LETTER - Jubilant Draximage Radiopharmacies Inc - 2015-01-07](https://www.keypedia.com/records/state_referral_letter/jubilant-draximage-radiopharmacies-inc/1c358fa4-b6f0-4019-8556-4c046dc77b4d) — source: FDA, date: January 7, 2015

## Related Companies

- [Hartley Medical Center Pharmacy, Incorporated](https://www.keypedia.com/companies/hartley-medical-center-pharmacy-incorporated/91d66c50-5d07-4596-a29c-d19b3cc0eeca)
- [Pentec Health](https://www.keypedia.com/companies/pentec-health/4085fb8f-bfbe-4fc2-a212-f3303a2fca73)
- [The Wellness Pharmacy](https://www.keypedia.com/companies/the-wellness-pharmacy/c8db9164-7349-4ed1-820c-7b244cc05af2)
- [Kalman Health & Wellness, Inc.](https://www.keypedia.com/companies/kalman-health-wellness-inc/85a19fa4-bd4a-45d7-9277-a5a990281bd5)
- [Revive Rx LLC dba Revive Rx Pharmacy](https://www.keypedia.com/companies/revive-rx-llc-dba-revive-rx-pharmacy/76ca0e11-cf06-411e-a944-bb16f40464d4)
- [Innovative Compounding Pharmacy](https://www.keypedia.com/companies/innovative-compounding-pharmacy/22113e00-3e7e-47cf-9c38-2cc4063e7a4d)
- [Edge Pharma, LLC](https://www.keypedia.com/companies/edge-pharma-llc/8e1a2d92-d72f-4102-8b1a-e37e96a75b69)
- [Healthy Choice Compounding LLC](https://www.keypedia.com/companies/healthy-choice-compounding-llc/6ed01710-4033-40b2-8736-0630cc237e1e)
- [InfuScience, Inc. dba Bioscrip Infusion Services](https://www.keypedia.com/companies/infuscience-inc-dba-bioscrip-infusion-services/6fb79324-4213-45fa-878b-073a1bccf737)
- [Molecular PharmaGroup](https://www.keypedia.com/companies/molecular-pharmagroup/284f8e5d-cf64-49a4-80cb-59cd24428b20)

## Related Officers

- [Russell J. Glapion](https://www.keypedia.com/people/russell-j-glapion/54dd6274-563a-44fe-8016-2ebd700be7a0)
- [James Flahive](https://www.keypedia.com/people/james-flahive/8d9773e4-d821-4988-9baa-0aa57704e54e)
- [Kimberly A. Grinston](https://www.keypedia.com/people/kimberly-a-grinston/645eb345-a9e4-4707-909c-abd22c176b20)
- [Investigator](https://www.keypedia.com/people/danial-s-hutchison/5fa8c19d-7e3c-4ebd-bd8c-3c8d74eaa206)
- [Director of Compliance](https://www.keypedia.com/people/nicholas-f-lyons/e52983af-3992-493c-addd-ff1dfa59eefb)
- [Joseph M. Huber](https://www.keypedia.com/people/joseph-m-huber/14621ecb-4b4d-4044-bb2e-60bcb3e2809c)
